Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma ; volume:18 ; number:1 ; day:20 ; month:12 ; year:2018 ; pages:1-10 ; date:12.2018
BMC cancer ; 18, Heft 1 (20.12.2018), 1-10, 12.2018
- Creator
-
Liu, Sai-Lan
Sun, Xue-Song
Li, Xiao-Yun
Chen, Qiu-Yan
Lin, Huan-Xin
Wen, Yue-Feng
Guo, Shan-Shan
Liu, Li-Ting
Xie, Hao-Jun
Tang, Qing-Nan
Liang, Yu-Jing
Yan, Jin-Jie
Lin, Chao
Yang, Zhen-Chong
Tang, Lin-Quan
Guo, Ling
Mai, Hai-Qiang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-5192-x
- URN
-
urn:nbn:de:101:1-2019020322595327395906
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Sai-Lan
- Sun, Xue-Song
- Li, Xiao-Yun
- Chen, Qiu-Yan
- Lin, Huan-Xin
- Wen, Yue-Feng
- Guo, Shan-Shan
- Liu, Li-Ting
- Xie, Hao-Jun
- Tang, Qing-Nan
- Liang, Yu-Jing
- Yan, Jin-Jie
- Lin, Chao
- Yang, Zhen-Chong
- Tang, Lin-Quan
- Guo, Ling
- Mai, Hai-Qiang
- SpringerLink (Online service)
Other Objects (12)
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Paclitaxel, Imatinib, and 5-Fluorouracil increase the unbound fraction of flucloxacillin in vitro
Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable locally advanced esophageal and esophagogastric junctional adenocarcinoma
PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma
Impact of preoperative docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy on degree of malignant esophageal stenosis
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)
Palliative Therapie des rezidivierten Kopf-Hals-Karzinoms : ein retrospektiver Vergleich der Taxane Paclitaxel und Docetaxel
Neoadjuvante Chemotherapie mit Paclitaxel, Cisplatin, Leucovorin und 5-Fluorouracil beim lokal fortgeschrittenen Adenokarzinom des Ösophagus
Neoadjuvante Chemotherapie mit Paclitaxel, Cisplatin, Leucovorin und 5-Fluorouracil beim lokal fortgeschrittenen Adenokarzinom des Ösophagus
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Paclitaxel, Imatinib, and 5-Fluorouracil increase the unbound fraction of flucloxacillin in vitro
Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable locally advanced esophageal and esophagogastric junctional adenocarcinoma
PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma
Impact of preoperative docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy on degree of malignant esophageal stenosis
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)
Palliative Therapie des rezidivierten Kopf-Hals-Karzinoms : ein retrospektiver Vergleich der Taxane Paclitaxel und Docetaxel
Neoadjuvante Chemotherapie mit Paclitaxel, Cisplatin, Leucovorin und 5-Fluorouracil beim lokal fortgeschrittenen Adenokarzinom des Ösophagus
Neoadjuvante Chemotherapie mit Paclitaxel, Cisplatin, Leucovorin und 5-Fluorouracil beim lokal fortgeschrittenen Adenokarzinom des Ösophagus
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Paclitaxel, Imatinib, and 5-Fluorouracil increase the unbound fraction of flucloxacillin in vitro
Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable locally advanced esophageal and esophagogastric junctional adenocarcinoma
PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma
Impact of preoperative docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy on degree of malignant esophageal stenosis
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)
Palliative Therapie des rezidivierten Kopf-Hals-Karzinoms : ein retrospektiver Vergleich der Taxane Paclitaxel und Docetaxel
Neoadjuvante Chemotherapie mit Paclitaxel, Cisplatin, Leucovorin und 5-Fluorouracil beim lokal fortgeschrittenen Adenokarzinom des Ösophagus
Neoadjuvante Chemotherapie mit Paclitaxel, Cisplatin, Leucovorin und 5-Fluorouracil beim lokal fortgeschrittenen Adenokarzinom des Ösophagus
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer